Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait

PHASE4CompletedINTERVENTIONAL
Enrollment

603

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Omeprazole, Amoxicillin, Metronidazole and Clarithromycin

The first group (standard triple therapy group) received omeprazole 20 mg, amoxicillin 1 g and clarithromycin 500 mg. The second group (quadruple therapy group) received omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg. Patients in both groups received omeprazole capsule twice daily before meals and the rest of the drugs twice daily after meals for 14 days.

DRUG

Omeprazole, Amoxicillin and Clarithromycin

The first group (standard triple therapy group) received omeprazole 20 mg, amoxicillin 1 g and clarithromycin 500 mg. The second group (quadruple therapy group) received omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg. Patients in both groups received omeprazole capsule twice daily before meals and the rest of the drugs twice daily after meals for 14 days.

All Listed Sponsors
collaborator

Ministry of Health, Kuwait

OTHER_GOV

lead

Al-Azhar University

OTHER

NCT04617613 - Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait | Biotech Hunter | Biotech Hunter